For example, at the extremes, NLRX1 was found to be up-regulated 2.72 fold in squamous cell carcinoma of the skin compared to normal skin, while being down-regulated 8.1 fold in high grade myxoid liposarcoma tumors compared to normal adipose tissue (Figure 1A). Here, NLRX1 is linked to skin squamous cell carcinoma.